Useful information

Prime News delivers timely, accurate news and insights on global events, politics, business, and technology

Breakthrough T1D Play has raised $5 million for diabetes research


He Innovative game for Type 1 diabetes The program is a medical research charity that raises money for critical research into diabetes, a leading cause of death in the US.

And this week, pioneer of games. Will Wright helped raise money for the group, said Wright and Josh Larson, national director of Breakthrough T1D Play, in interviews with GamesBeat.

Wright talked about his career, creating games like Sim City, The Sims and more at companies like Maxis and Electronic Arts. The Sims franchise has generated more than $5 billion in revenue to date.

He is now co-founder of his own startup Gallium Studios with Lauren Elliott and they are working on a memory simulation game called Next. Wright, whose grandmother had type 1 diabetes, also gave a preview of what Proxi will become as part of a drive to raise money for the nonprofit.

Will Wright’s new game is Proxi.

Proxi is a new life simulation game about making magical connections with your memories and bringing them to life. The game is a lot like quantifying your memories, Wright said in an interview with GamesBeat.

In an interview, Wright noted that there are a couple of people in his family with type 1 diabetes, as well as other people among friends and also at his workplace. That gave him good reasons to stream with Breakthrough T1D Play.

The Breakthrough T1D program focuses on cures for type 1 diabetes, a disease that affects one in 400 children. More than 1.6 million Americans have type 1 diabetes (T1D), and 9.4 million suffer from it worldwide. It is on track to grow to 16 million by 2040. Although people can make lifestyle changes to help manage the disease, there is no cure at this time.

The Breakthrough T1D Play group was formed in 2019. It was founded by gaming industry veterans who are parents of children with type 1 diabetes. And they have raised over $5 million for research into new treatments and potential cures.

The program is supported by a powerful network of gaming industry veterans who have type 1 diabetes or have a close personal connection, from companies like Microsoft, PlayStation, EA and Disney. With your support, Breakthrough T1D Play raises money and awareness through Humble Packages, steam sales, charity streamsand in-game integrations.

In the group’s Dev Diaries Twitch series, members of the Breakthrough T1D Play streaming community interview game developers about their careers while talking about their connection to type 1 diabetes (when applicable) and playing a game they worked on .

Wright joined to talk and play The Sims 2 and show off the new life simulator called Proxi. One of the programmers at Gallium Studios, Justin Graham, a LucasArts and Maxis alumnus, is working on Proxi and has type 1 diabetes.

The Sims have a unique connection to the T1D community, such as The Sims 4 Added Wearable Medical Devices Including CGMs and Pumps to the game, Larson said.

“Our gaming show raises awareness and funding for type 1 diabetes research. I’m still smiling today because we had Will Wright on a stream on our Twitch channel. It was a great moment for us,” Larson said. “We want to be where people play, where they buy games and where they watch games.”

A great aspect of Breakthrough T1D Play is that gaming-adjacent people constantly come out of the woodwork to tell us about their connections to T1D, helping us grow our network within the gaming industry and build our community among gamers. and streamers. During yesterday’s Twitch stream, Will surprised us by mentioning that his grandfather had type 1 diabetes.

In the past, living with diabetes was difficult because the disease affected the body’s ability to make insulin, which removes sugar, or glucose, from the bloodstream. If that sugar remains in the body, it can be very harmful and cause serious illness or even death. That means people with diabetes need to monitor their glucose levels and make sure they stay within an acceptable range.

Will Wright joins the Breakthrough T1D Play livestream.

In recent years there have been some advances in treatment. An automated insulin delivery (AID) system can now connect an insulin pump, a continuous glucose monitor (CGM), and use an algorithm that regulates insulin dosage to help you stay in range.

Type 1 diabetes is not related to diet, health and lifestyle. But people can get type 2 diabetes if they don’t control their diet properly. And the more obese the population becomes, the more likely type 2 diabetes becomes.

I’ve tried glucose monitors a couple of times to see the impact of carbs and sugar on my body, and it’s pretty enlightening to see the immediate impact on my body. But others have to use it to avoid much more serious consequences.

Larson’s 13-year-old son was diagnosed seven years ago and has had to wear a continuous glucose monitor all the time. You now also have an insulin pump that automatically delivers insulin as needed, thanks to an algorithm. That reduces caregiver awakenings in the middle of the night, Larson said.

Larson said her daughter has been using the DIY Loop system for 4.5 years and it has been a game-changer for the family. The results have been very positive and Breakthrough T1D advocacy efforts continue to work to improve access to this technology. In fact, the NHS in the United Kingdom has recommended these systems and is expanding access.

“There have actually been more solutions available in recent years,” Larson said.

However, the AID systems mentioned above do not represent a cure for type 1 diabetes and do not alleviate the burden of those living with it. Meanwhile, the first disease-modifying treatment for type 1 diabetes, Tzield, was recently approved by the FDA and can prevent the onset of type 1 diabetes in high-risk people for up to three years.

Larson said he is hopeful when it comes to finding functional cures for the disease. Advances in cell therapies promoted Breakthrough T1D will launch the ACT Project (Accelerate Cell Therapies), an initiative to advance and accelerate commercially available stem cell-based islet cell therapies. In general, research focuses on treatment, prevention and cure, Larson said.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *